Igor Odintsov

674 total citations · 1 hit paper
15 papers, 260 citations indexed

About

Igor Odintsov is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Igor Odintsov has authored 15 papers receiving a total of 260 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Igor Odintsov's work include Sarcoma Diagnosis and Treatment (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Igor Odintsov is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). Igor Odintsov collaborates with scholars based in United States, Canada and United Kingdom. Igor Odintsov's co-authors include Ming Y. Lu, Long P. Le, Andrew Zhang, Drew F. K. Williamson, Bowen Chen, Ivy Liang, Richard J. Chen, Tong Ding, Anil V. Parwani and Faisal Mahmood and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Annals of Oncology.

In The Last Decade

Igor Odintsov

11 papers receiving 253 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A visual-language foundation model for computational pathology

2024 228 citations Ming Y. Lu, Bowen Chen et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Igor Odintsov United States	5	143	98	52	40	37	15	260
Adrian Ion‐Mărgineanu United States	7	107 0.7×	131 1.3×	26 0.5×	39 1.0×	39 1.1×	16	314
Adrian Levine Canada	7	102 0.7×	105 1.1×	23 0.4×	53 1.3×	43 1.2×	25	287
Nick Weiss Germany	10	176 1.2×	151 1.5×	104 2.0×	39 1.0×	49 1.3×	16	353
Charles Maussion France	4	190 1.3×	178 1.8×	34 0.7×	30 0.8×	67 1.8×	12	338
Andrea M. Olofson United States	7	186 1.3×	182 1.9×	47 0.9×	26 0.7×	124 3.4×	13	324
Brendon Lutnick United States	7	159 1.1×	78 0.8×	85 1.6×	40 1.0×	43 1.2×	18	306
Ivy Liang United States	2	228 1.6×	161 1.6×	72 1.4×	52 1.3×	38 1.0×	3	385
W. Roger Williams United States	2	201 1.4×	156 1.6×	65 1.3×	48 1.2×	52 1.4×	2	360
Emmanuel Agosto‐Arroyo United States	5	207 1.4×	148 1.5×	47 0.9×	44 1.1×	81 2.2×	11	327
Ayesha Azam United Kingdom	4	144 1.0×	118 1.2×	22 0.4×	31 0.8×	86 2.3×	7	236

Countries citing papers authored by Igor Odintsov

Since Specialization

Citations

This map shows the geographic impact of Igor Odintsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Odintsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Odintsov more than expected).

Fields of papers citing papers by Igor Odintsov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Igor Odintsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Odintsov. The network helps show where Igor Odintsov may publish in the future.

Co-authorship network of co-authors of Igor Odintsov

This figure shows the co-authorship network connecting the top 25 collaborators of Igor Odintsov. A scholar is included among the top collaborators of Igor Odintsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Igor Odintsov. Igor Odintsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Odintsov, Igor, Dale Davis, Daniel Pissaloux, et al.. (2025). BRAF Gene Fusions in Melanoma. The American Journal of Surgical Pathology. 49(5). 429–438.

Papke, David, Sándor Kovács, Igor Odintsov, et al.. (2025). Malignant Giant Cell Tumor of Bone. The American Journal of Surgical Pathology. 49(6). 539–553. 2 indexed citations

Odintsov, Igor, et al.. (2025). 1691 A Complementary Role for Immunohistochemistry and NGS for Detection of MTAP Gene Deletion in Patients with Non-Small Cell Lung Cancer. Laboratory Investigation. 105(3). 103936–103936. 1 indexed citations

Odintsov, Igor, et al.. (2025). MUC4-positive Fibroblastoma. The American Journal of Surgical Pathology. 49(11). 1125–1132.

Lu, Ming Y., Bowen Chen, Drew F. K. Williamson, et al.. (2024). A visual-language foundation model for computational pathology. Nature Medicine. 30(3). 863–874. 228 indexed citations breakdown →

Odintsov, Igor, Harrison Tsai, Brendan C. Dickson, et al.. (2024). Epithelioid Fibrous Histiocytoma Is on a Continuum With Superficial ALK-rearranged Myxoid Spindle Cell Neoplasm. The American Journal of Surgical Pathology. 48(12). 1568–1579. 5 indexed citations

Papke, David, Igor Odintsov, Brendan C. Dickson, et al.. (2024). Myxoid Inflammatory Myofibroblastic Sarcoma. The American Journal of Surgical Pathology. 48(8). 1005–1016. 7 indexed citations

Lo, Ying‐Chun, et al.. (2023). Integrating Molecular Sequencing Into the Pathological Diagnosis of Clinically Suspected Non–Small Cell Lung Carcinomas. Modern Pathology. 36(5). 100126–100126. 2 indexed citations

Vojnic, Morana, Igor Odintsov, Zhifeng Liu, et al.. (2023). 2295P Pan-cancer prevalence of MET fusions and clinical response to MET- targeted therapy. Annals of Oncology. 34. S1175–S1175.

10.

Kang, Yu Mi, Douglas A. Rubinson, Igor Odintsov, et al.. (2023). FRI610 Phosphatidylinositol 3-kinase Inhibition With Alpelisib Is Safe And Effective In Treating Refractory Hypoglycemia Associated With Malignant Insulinoma. Journal of the Endocrine Society. 7(Supplement_1).

11.

Odintsov, Igor, Masanori Kato, Inna Khodos, et al.. (2023). Abstract B157: Preclinical evaluation of the blood-brain barrier permeability and intracranial efficacy of the next-generation RET inhibitor Vepafestinib. Molecular Cancer Therapeutics. 22(12_Supplement). B157–B157. 1 indexed citations

12.

Odintsov, Igor, Fei Dong, Jeffrey P. Guenette, et al.. (2023). Infantile Sinonasal Myxoma Is Clinically and Genetically Distinct From Other Myxomas of the Craniofacial Bones and From Desmoid Fibromatosis. The American Journal of Surgical Pathology. 47(11). 1301–1315. 4 indexed citations

13.

Odintsov, Igor, Jyothi P. Jagannathan, Alyaa Al‐Ibraheemi, et al.. (2022). Primary Clear Cell Sarcoma of Bone. The American Journal of Surgical Pathology. 47(3). 354–360. 1 indexed citations

14.

Odintsov, Igor, Kota Ishizawa, Isao Miyazaki, et al.. (2022). Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases.. Journal of Clinical Oncology. 40(16_suppl). 2024–2024. 8 indexed citations

15.

Odintsov, Igor, et al.. (2022). Vepafestinib is effective in preclinical models of sarcomas with RET fusion including a brain metastasis model. European Journal of Cancer. 174. S27–S27. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact